H-1B Filings
17
Major sponsor. DOL labor condition applications on file.
BioMarin Pharmaceutical Inc. in CA (Manufacturing) shows all three federal tracks on this profile: 17 H-1B LCAs, an employer OSHA injury record, and 9 WARN notices.
BioMarin Pharmaceutical Inc. (CA): · 17 H-1B LCAs at a $180,070 disclosed median · OSHA Grade B (DART 0.66) · 9 WARN notices
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, BioMarin Pharmaceutical Inc. in CA carries 17 H-1B wage filings on record, a $180,070 median wage (above the $124,488 national median), a solid B OSHA safety grade and 9 WARN layoff notices on file. Every figure is a federal filing, not an estimate; see methodology for coverage limits.
Layoff & federal record
Compared with the rest of PlainEmployers' federal employer corpus, H-1B filing volume ranks #3,044 of 51,370 sponsors in this corpus (about the 94th percentile), and disclosed median wage sits at the 83rd percentile of 272,125 credible H-1B wage rows.
Figures above come from DOL H-1B LCAs, this employer's OSHA injury log, and state WARN notices, three independent disclosure systems.
A weighted composite of DOL H-1B sponsorship and pay, OSHA establishment injury records, and WARN Act layoff notices, not culture, benefits, or "is this a good place to work." Missing tracks drop out and their weight redistributes so sparse records are not silently deflated.
Weights (redistributed when a track is N/A): Sponsorship scale (H-1B volume) 15% · Disclosed pay (H-1B wage percentile) 25% · Workplace safety (OSHA DART percentile) 35% · Layoff stability (WARN percentile) 25%. Sources: DOL OFLC · OSHA ITA · state WARN filings.
DOL LCA release change
H-1B Filings
17
Major sponsor. DOL labor condition applications on file.
Median H-1B Salary
$180,070
Above national median. Across 17 disclosed positions
OSHA Safety Grade
Grade B · DART 0.66
Safer than industry average. vs 1.14 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)
WARN Workforce Impact
373 workers
Less stable than most peers. 9 WARN Act notices on file
Where BioMarin Pharmaceutical Inc.'s H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$180,070 Top 17% higher than 83% of 272,125 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
Filing-count-weighted median across this employer's own disclosed H-1B positions (+31% year over year), not a company-wide raise, and not adjusted for role mix changes between years.
| Field | Value | Source |
|---|---|---|
| Employer Name | BioMarin Pharmaceutical Inc. | DOL OFLC / OSHA / WARN |
| Industry | Manufacturing | NAICS / DOL |
| State | CA | U.S. Federal Records |
| H-1B Filings | 17 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $180,070 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | B | OSHA ITA |
| OSHA DART Rate | 0.66 | OSHA ITA Establishment Records |
| WARN Layoff Notices | 9 notice(s), 373 workers | WARN Act notices, state workforce agency originals (archival backstop: LayoffData.com) |
BioMarin Pharmaceutical Inc.'s values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records, WARN Act notices on file for this employer in CA (Manufacturing). In this corpus, H-1B filing volume ranks #3,044 of 51,370 sponsors in this corpus (about the 94th percentile); disclosed median wage sits at the 83rd percentile of 272,125 credible H-1B wage rows; OSHA DART rate is safer than roughly 57% of 214,554 employers with an establishment injury record.
| Job Title | Median |
|---|---|
| Medical Director, Drug Safety Surveillance | $252,331 |
| Executive Director, Global Commercial Lead, Achondroplasia | $235,934 |
| VP, Head of Commercial Digital Strategy and Transformation | $235,934 |
| Director “ Global Technology Transfer | $204,859 |
| Associate Director, Sales Analytics | $202,978 |
| Associate Director, Information Technology | $200,304 |
| Director, Molecular Engineering | $193,170 |
| Manager, ERP Systems | $186,035 |
| Senior IM Business Systems Analyst Manager | $180,070 |
| Associate Director, Site Technical Lead | $156,270 |
| Scientist 2, Neuroscience Research | $146,162 |
| Sr. Solutions Engineer | $133,952 |
| Sr. Research Associate 1, Oligo. Protein Bioconjugate Prod. | $127,475 |
| Supervisor, QC Microbiology | $107,952 |
| Sr. Research Associate 1, Tech Ops | $92,000 |
| Research Associate 2, Flow Cytometry Core | $85,197 |
| Research Associate 2 | $60,757 |
WARN history dominates: 9 notices put this employer among the 100% with the heaviest layoff filings in the corpus.
BioMarin Pharmaceutical Inc. in CA (Manufacturing) filed 17 H-1B labor condition applications at a $180,070 disclosed median — a top-tercile sponsorship footprint in this corpus.
FY2025 added 4 filings versus FY2024 (80%), a sponsorship expansion visible in the raw LCA counts.
Disclosed medians moved from $139,815 (FY2024) to $183,178 (FY2025) (+31%), weighted by this employer's own LCA rows — not a company-wide raise and not role-mix adjusted.
Disclosed pay runs high: $180,070 median beats 83% of credible wage rows and sits above the $124,488 national median.
DART 0.7 tracks close to the 1.1 sector average (Grade B).
BioMarin Pharmaceutical Inc. is one of the rarer profiles carrying both sponsorship volume (17 H-1B LCAs) and WARN history (9 notices) in the same public record (Manufacturing) in CA. Weigh those signals separately.
BioMarin Pharmaceutical Inc.'s DART rate (days away/restricted/transferred per 100 FTE) vs the hours-weighted 2-digit NAICS sector average from OSHA ITA 2022–2023 (Manufacturing).
Total reported injuries on file: 20.
Where BioMarin Pharmaceutical Inc. sits
Across the 201 Manufacturing sponsors in this corpus with both an H-1B filing count and a credible disclosed-wage median, BioMarin Pharmaceutical Inc. files more petitions than 0% of them and discloses a higher median wage than 94%, the selective, above-median pay quadrant. Filing volume is hiring scale, not pay; the axes are independent DOL OFLC disclosures (17 filings · $180,070 median here).
Each muted dot is one manufacturing peer from a filings-stratified sample of 42; the brand marker is BioMarin Pharmaceutical Inc.. Source: DOL Office of Foreign Labor Certification H-1B LCA disclosures (credible wages recomputed from per-position filings, excluding parse errors above $500k).
BioMarin Pharmaceutical Inc.'s nearest H-1B-filing peers in Manufacturing (home state CA). Each card links to that employer's federal-records profile.
Two federal-records peer sets for BioMarin Pharmaceutical Inc., both outside CA so the neighborhoods are not the same-industry VsCard above.
Nearest injury-rate peers outside CA (DART 0.66 here).
Peers are nearest-neighbor matches on disclosed filing counts and OSHA ITA DART rates; employers with fewer than 100 H-1B filings or fewer than 10 reported injuries are excluded from the comparison corpus.
| Notice Date | Workers |
|---|---|
| 2024-09-03 | 94 |
| 2024-09-03 | 52 |
| 2024-09-03 | 1 |
| 2024-05-14 | 57 |
| 2024-05-14 | 71 |
| 2024-05-14 | 3 |
| 2024-05-14 | 1 |
| 2022-10-10 | 62 |
| 2022-10-10 | 32 |
What to check before working with BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. needs a three-way read: H-1B pay (17 LCAs), safety (grade B), and WARN history (9 notices); none of those alone is the rating.
BioMarin Pharmaceutical Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Among 272,125 credible H-1B wage rows in this corpus, BioMarin Pharmaceutical Inc.'s disclosed median of $180,070 sits at the 83rd percentile (above the $124,488 national median). The chart above uses a COUNT-exact percentile (rows below this wage ÷ total), not an interpolated estimate.
BioMarin Pharmaceutical Inc. has 17 H-1B filings on record, ranking #3,044 of 51,370 sponsors in this corpus (about the 94th percentile by volume). Filing volume is a sponsorship signal, not a headcount or hiring-quality score.
BioMarin Pharmaceutical Inc. carries Grade B from its establishment injury record (20 injuries on file; DART 0.66). That DART rate is safer than roughly 57% of 214,554 employers with an injury record in this corpus. Grades compare DART against industry averages, see the Interpreting Safety Grades guide.
Yes - 9 WARN Act notices affecting about 373 workers appear in the state-agency corpus for this employer. WARN covers mass layoffs and plant closings that meet statutory thresholds; absence of notices is not a guarantee of stability.
Related guides: How OSHA safety grades are calculated · Using H-1B wage filings in salary negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings, OSHA Injury Tracking Application records and state WARN Act layoff notices, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.